# Pasireotide in the Treatment of Hypoglycemia Following Gastric Bypass Surgery

> **NCT03514576** · PHASE4 · UNKNOWN · sponsor: **Zealand University Hospital** · enrollment: 5 (estimated)

## Conditions studied

- Hypoglycemia, Reactive

## Interventions

- **DRUG:** Pasireotide 0.3 MG/ML
- **DIAGNOSTIC_TEST:** Meal tolerance test (MTT)

## Key facts

- **NCT ID:** NCT03514576
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2018-08-01
- **Final completion:** 2018-11-01
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03514576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03514576, "Pasireotide in the Treatment of Hypoglycemia Following Gastric Bypass Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03514576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*